This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nord, C E
Right arrow Articles by Norrby, S R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nord, C E
Right arrow Articles by Norrby, S R

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1991 March; 35(3): 594-599

Susceptibility of anaerobic bacteria to BAY v 3522.

C E Nord, M Rylander and S R Norrby

Department of Microbiology, Huddinge University Hospital, Stockholm, Sweden.

ABSTRACT

The activity of BAY v 3522 against 340 strains of anaerobic bacteria was determined by an agar dilution method. Its activity was compared with those of amoxicillin, amoxicillin-clavulanate, cefaclor, cefadroxil, cefoxitin, cefuroxime, cephalexin, clindamycin, doxycycline, and metronidazole. BAY v 3522, amoxicillin-clavulanate, cefoxitin, clindamycin, and metronidazole were the most active agents tested. On the basis of these results, BAY v 3522 appears to have an antibacterial activity that warrants further investigation in clinical trials.


Antimicrob Agents Chemother. 1991 March; 35(3): 594-599




This article has been cited by other articles:

  • Paker, G. E., Graham, J. A., Rauch, A. M., Collins, J. J. (1994). Cefuroxime Axetil in the Treatment of Sinusitis: A Review. Arch Fam Med 3: 165-175 [Abstract]